Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study

被引:17
|
作者
Schmidt, Felix A. [1 ,2 ,3 ,4 ,5 ]
Chien, Claudia [1 ,2 ,3 ]
Kuchling, Joseph [1 ,2 ,3 ,4 ]
Bellmann-Strobl, Judith [1 ,2 ,3 ,6 ,7 ]
Ruprecht, Klemens [2 ,3 ,4 ,5 ]
Siebert, Nadja [1 ,2 ,3 ,6 ,7 ]
Asseyer, Susanna [1 ,2 ,3 ,6 ,7 ]
Jarius, Sven [8 ]
Brandt, Alexander U. [1 ,2 ,3 ,6 ,7 ,9 ]
Scheel, Michael [1 ,2 ,3 ,10 ]
Paul, Friedemann [1 ,2 ,3 ,4 ,6 ,7 ]
机构
[1] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[3] Berlin Inst Hlth, Berlin, Germany
[4] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[5] Charite Univ Med Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Dept Neurol, Berlin, Germany
[6] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany
[7] Charite Univ Med Berlin, Berlin, Germany
[8] Univ Hosp Heidelberg, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany
[9] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[10] Charite Univ Med Berlin, Dept Neuroradiol, Berlin, Germany
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
NMOSD; AQP4; MOG; MRI; DTI; advanced imaging; WHITE-MATTER; SPINAL-CORD; BRAIN; DISEASE; DAMAGE; ASSOCIATION; MULTICENTER; AQUAPORIN-4; FEATURES; CRITERIA;
D O I
10.3389/fneur.2020.499910
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims:To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods:33 AQP4-IgG and 18 MOG-IgG seropositive NMOSD patients and 61 healthy control (HC) subjects were included. All 112 participants were scanned with the same standardized MRI-protocol on a 3-Tesla MRI-scanner. Brain volume and diffusion tensor imaging (DTI) parameters were assessed. Results:MOG-IgG+ patients showed reduced parallel diffusivity within white matter tracts compared to HC whereas AQP4-IgG+ showed no significant brain parenchymal damage in DTI analysis. AQP4-IgG+ patients showed reduced whole brain volumes and reduced volumes of several deep gray matter structures compared to HC whereas MOG-IgG+ patients did not show reduced brain or deep gray matter volumes compared to HC. Conclusions:Microstructural brain parenchymal damage in MOG-IgG+ patients was more pronounced than in AQP4-IgG+ patients, compared with HC, whereas normalized brain volume reduction was more severe in AQP4-IgG+ patients. Longitudinal imaging studies are warranted to further investigate this trend in NMOSD. Our results suggest that MOG-IgG+ and AQP4-IgG+ NMOSD patients differ in cerebral MRI characteristics. Advanced MRI analysis did not help to differentiate between MOG-IgG+ and AQP4-IgG+ patients in our study.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Early predictors of disability of paediatric-onset AQP4-IgG seropositive neuromyelitis optica spectrum disorders
    Camera, V.
    Messina, S.
    Elhadd, K. T.
    Sanpera-Iglesias, J.
    Mariano, R.
    Hacohen, Y.
    Dobson, R.
    Meletti, S.
    Wassmer, E.
    Lim, M.
    Huda, S.
    Hemingway, C.
    Leite, M. I.
    Ramdas, S.
    Palace, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 149 - 150
  • [12] Paraneoplastic seropositive AQP4-IgG neuromyelitis optica spectrum disorder associated with sigmoid adenocarcinoma
    Hassan, Sarah Hasnor Abu
    Sonu, Sumit Kumar
    [J]. NEUROLOGY ASIA, 2023, 28 (03) : 769 - 774
  • [13] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Tradtrantip, Lukmanee
    Yeaman, Michael R.
    Verkman, A. S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [14] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Lukmanee Tradtrantip
    Michael R. Yeaman
    A. S. Verkman
    [J]. Scientific Reports, 11
  • [15] Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
    Palace, Jacqueline
    Lin, Dan-Yu
    Zeng, Donglin
    Majed, Masoud
    Elsone, Liene
    Hamid, Shand
    Messina, Silvia
    Misu, Tatsuro
    Sagen, Jessica
    Whittam, Daniel
    Takai, Yoshiki
    Leite, Maria Isabel
    Weinshenker, Brian
    Cabre, Philippe
    Jacob, Anu
    Nakashima, Ichiro
    Fujihara, Kazuo
    Pittock, Sean J.
    [J]. BRAIN, 2019, 142 : 1310 - 1323
  • [16] AQP4-IgG antibodies as biomarkers for early diagnosis of neuromyelitis optica spectrum disorders
    Mader, Simone
    Deisenhammer, Florian
    Reindl, Markus
    [J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 337 - 342
  • [17] Rapid AQP4-IgG detection in neuromyelitis optica spectrum disorder
    Heather Wood
    [J]. Nature Reviews Neurology, 2023, 19 : 638 - 638
  • [18] Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
    Motamedi, Seyedamirhosein
    Oertel, Frederike C.
    Yadav, Sunil K.
    Kadas, Ella M.
    Weise, Margit
    Havla, Joachim
    Ringelstein, Marius
    Aktas, Orhan
    Albrecht, Philipp
    Ruprecht, Klemens
    Bellmann-Strobl, Judith
    Zimmermann, Hanna G.
    Paul, Friedemann
    Brandt, Alexander U.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (05):
  • [19] Rapid AQP4-IgG detection in neuromyelitis optica spectrum disorder
    Wood, Heather
    [J]. NATURE REVIEWS NEUROLOGY, 2023, 19 (11) : 638 - 638
  • [20] Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort
    Dahan, Ariel
    Dale, Russell
    Brilot, Fabienne
    Kornberg, Andrew
    Yiu, Eppie
    [J]. NEUROLOGY, 2016, 86